Selected article for: "biological activity and molecule activity"
Author: Gorini, Francesca; Del Turco, Serena; Sabatino, Laura; Gaggini, Melania; Vassalle, Cristina
Title: H(2)S as a Bridge Linking Inflammation, Oxidative Stress and Endothelial Biology: A Possible Defense in the Fight against SARS-CoV-2 Infection?
  • Cord-id: 3gcr7w8t
  • Document date: 2021_8_28
    • ID: 3gcr7w8t
    Snippet: The endothelium controls vascular homeostasis through a delicate balance between secretion of vasodilators and vasoconstrictors. The loss of physiological homeostasis leads to endothelial dysfunction, for which inflammatory events represent critical determinants. In this context, therapeutic approaches targeting inflammation-related vascular injury may help for the treatment of cardiovascular disease and a multitude of other conditions related to endothelium dysfunction, including COVID-19. In r
    Document: The endothelium controls vascular homeostasis through a delicate balance between secretion of vasodilators and vasoconstrictors. The loss of physiological homeostasis leads to endothelial dysfunction, for which inflammatory events represent critical determinants. In this context, therapeutic approaches targeting inflammation-related vascular injury may help for the treatment of cardiovascular disease and a multitude of other conditions related to endothelium dysfunction, including COVID-19. In recent years, within the complexity of the inflammatory scenario related to loss of vessel integrity, hydrogen sulfide (H(2)S) has aroused great interest due to its importance in different signaling pathways at the endothelial level. In this review, we discuss the effects of H(2)S, a molecule which has been reported to demonstrate anti-inflammatory activity, in addition to many other biological functions related to endothelium and sulfur-drugs as new possible therapeutic options in diseases involving vascular pathobiology, such as in SARS-CoV-2 infection.

    Search related documents:
    Co phrase search for related documents
    • ace expression and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • ace expression and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62
    • ace expression and adaptive innate: 1
    • ace expression and adaptive innate immunity: 1
    • ace expression and liver failure: 1
    • ace expression and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • ace expression and macrophage infiltration: 1
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • ace inhibitor and adaptive innate: 1
    • ace inhibitor and adaptive innate immunity: 1
    • ace inhibitor and lung injury: 1, 2, 3, 4
    • acetyl cysteine and acute lung injury: 1, 2, 3
    • acetyl cysteine and acute respiratory distress syndrome: 1, 2
    • acetyl cysteine and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acetyl cysteine and liver failure: 1